川恒股份(002895.SZ):終端產品已完成10萬噸/年的磷酸鐵產能建設
格隆匯5月18日丨川恒股份(002895.SZ)召開業績説明會,就“公司在新能源材料領域的佈局情況和進展如何?”
川恒股份表示,公司將不斷完善從磷礦石到磷酸鹽產品的磷化工產業鏈,大力實施“礦化一體”產業模式,推動終端產品結構從傳統磷化工向新能源材料升級轉型。公司在貴州福泉、甕安兩個“礦化一體”產業園項目正在建設中。截至目前,終端產品已完成10萬噸/年的磷酸鐵產能建設,其他產線建設在持續推進中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.